Metraipolis › archive › dc_6df6a07f3ccd

R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation — Europe PMC PMID:41959931

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41959931
DOI
10.4102/sajid.v41i1.790
License (as archived)
solo-consultazione
Archived
2026-11-04T07:40:21.692Z
SHA-256 of the archived text
9106940b1d3225743ba294b1c105549940ea6b801bcd6d68aea4a3b97df5ac8f
Stable URL of this page
https://metraipolis.com/documento/dc_6df6a07f3ccd

How to cite

R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation — Europe PMC PMID:41959931 — Europe PMC (en), https://europepmc.org/article/MED/41959931 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6df6a07f3ccd (Metraipolis archive dc_6df6a07f3ccd, sha256 9106940b1d3225743ba294b1c105549940ea6b801bcd6d68aea4a3b97df5ac8f)
BibTeX
@misc{dc6df6a07f3ccd,
  title = {R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation — Europe PMC PMID:41959931},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41959931},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6df6a07f3ccd; sha256 9106940b1d3225743ba294b1c105549940ea6b801bcd6d68aea4a3b97df5ac8f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41959931. Agents can read the archived copy with the MCP tool read_document.